Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thyroid Neoplasms × Antibodies, Bispecific × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Advanced Solid Tumor 1

Interventions

Iodine-131 10 Thyrotropin Alfa 7 lenvatinib 6 Sorafenib 6 vandetanib 5 Thyroidectomy 5 Sunitinib 5 Saline Solution 5 pazopanib 4 Triiodothyronine 4 Vemurafenib 3 Thyroxine 3 Paclitaxel 3 Everolimus 3 Dexmedetomidine 3 Control Groups 3 AZD 6244 3 belinostat 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Immunohistochemistry 2 Gefitinib 2 Calcium Carbonate 2 Bupivacaine 2 Bortezomib 2 Azacitidine 2 Axitinib 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00467506 2011-11-11

RIT in MTC

Nantes University Hospital

Phase 2 Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡